The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04988295
Brief Title: A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure (MARIPOSA-2)

First Submitted : July 30, 2021
First Submitted that Met QC Criteria : July 30, 2021
First Posted : August 3, 2021

Last Update Submitted that Met QC Criteria : May 21, 2024
Last Update Posted : May 22, 2024